Neurology faculty part of newly-finished CCOM Impact Scholars installation
Three Department of Neurology faculty members are among the 46 Carver College of Medicine faculty recognized in the...
Helicopter vibrations launch stroke study
What initially began as an everyday annoyance, turned out to be a scientific discovery that has the potential to change the way clot-busting drugs are administered to stroke patients.
Leira coauthors COVID-19 stroke care recommendations published in Neurology
Enrique Leira, MD, MS, director of the Division of Cerebrovascular Disease in the University of Iowa Carver College of Medicine Department of Neurology and Head of the UI Health Care Comprehensive Stroke Center, was among a group of leaders in stroke care research who published early recommendations for stroke care during the COVID-19 pandemic.
University of Iowa team is first to stimulate human amygdala in SUDEP, breathing loss research
A team of University of Iowa neurology researchers found that electrical stimulation of the amygdala of an epilepsy patient can stop the patient from breathing without the patient even realizing breathing had stopped.
Gordon Buchanan, MD, PhD, Receives IOWA Award
Congratulations to Gordon Buchanan, MD, PhD, on receiving a fall 2019 Improving Our Workplace Award (IOWA). Buchanan was nominated by Alexandra Petrucci. He will be recognized at an IOWA reception in spring 2020.
UI doctors prepare to study obscure leading cause of death in refractory epilepsy
UI researchers are working to create a better understanding of the leading cause of death in refractory epilepsy cases.
UI-led rare disease consortium receives $7.2 million grant
The Inherited Neuropathy Consortium (INC) led by University of Iowa neurologist Michael Shy, MD, has received a five-year, almost $7.2 million grant renewal from the National Institutes of Health.
UI Group Led by Michael Shy, MD, One of Consortia to Receive Grant from Rare Diseases Clinical Research Network
NIH Funding Bolsters Rare Diseases Research Collaborations.
Prostate drug can “reduce the signs, symptoms, and complications of Parkinson’s disease”
Scientists discovered that terazosin can protect cells by activating an enzyme known as PGK1 that is crucial in producing cellular energy.
Basic research and big data combine to identify potential new use for prostate drug in treating Parkinson’s disease
A drug used to treat enlarged prostate may also be able to slow the progression of Parkinson’s disease.